WGS GeneDx
GeneDx earnings company data as of 8:58 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 27 Oct | EPS | 0.07 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by WGS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $107M bought by 2 insiders
- $6.1M sold by 1 insider outside a trading plan
- $511K sold by 1 insider under 10b5-1 plans
-
Casdin Capital, LLC Director, +3 joint filersBuy$11.1M 200,000 shares at $55.55 +5.7% to stakeTraded Jun 4–5 Filed Jun 8
-
Casdin Capital, LLC Director, +3 joint filersBuy$21.5M 500,000 shares at $42.92 +17% to stakeTraded May 18–20 Filed May 20
-
Keith A. Meister Director, +1 joint filerBuy$13.8M 351,273 shares at $39.19 +7.9% to stakeTraded May 13–15 Filed May 15
-
Keith A. Meister Director, +1 joint filerBuy$46.8M 1,205,147 shares at $38.84 +37% to stakeTraded May 7–11 Filed May 11
-
Keith A. Meister Director, +1 joint filerBuy$13.5M 169,521 shares at $79.40 +5.5% to stakeTraded Mar 3–5 Filed Mar 5
-
Bryan Dechairo COOPlanned sale$511K 5,961 shares at $85.70 100% of stakeTraded Feb 4 Filed Feb 6
-
Joshua Ruch DirectorSale$6.1M 38,000 shares at $160.37 24% of stakeTraded Nov 24, 2025 Filed Nov 26, 2025
Also filed in the last 12 months, not counted as buying or selling: 85 sales to cover taxes, 38 option exercises, and 4 stock grants.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.